InvaGen Pharmaceuticals, Inc. is 10% Owner at AVENUE THERAPEUTICS, INC. (ATXI). They have made 1 open-market trade across 1 company since 2022, most recently 2022-10-11.
CIK 0001759453
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ATXI | SELL | 2022-10-11 | 2022-10-13 | $7.71 | $6.0M | -16.6% | -45.2% | -64.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.